IDERA PHARMACEUTICALS INC - COM PAR (IDRA)

CUSIP: 45168K405

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM PAR
Total 13F shares
3,232,193
Share change
-244,619
Total reported value
$1,129,615
Price per share
$0.35
Number of holders
29
Value change
-$90,149
Number of buys
15
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 45168K405?
CUSIP 45168K405 identifies IDRA - IDERA PHARMACEUTICALS INC - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IDERA PHARMACEUTICALS INC - COM PAR (IDRA) as of Q4 2022

As of 31 Dec 2022, IDERA PHARMACEUTICALS INC - COM PAR (IDRA) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,232,193 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Credit Agricole S A, HOLLENCREST CAPITAL MANAGEMENT, STATE STREET CORP, MORGAN STANLEY, COMMONWEALTH EQUITY SERVICES, LLC, NORTHERN TRUST CORP, and UBS Group AG. This page lists 29 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.